Dr Simeone on the EVEREST-1 Trial Evaluating A2B530 in Solid Tumors

Diane M. Simeone, MD, discusses the phase 1/2 EVEREST-1 trial evaluating the autologous CAR T-cell therapy A2B530 in patients with solid tumors.

Related Keywords

United States ,Dianem Simeone , ,Perlmutter Cancer Center ,Grossman School Of Medicine ,Translational Research ,Department Of Pathology ,Department Of Surgery ,Pancreatic Cancer Center ,Isaac Perlmutter Professor ,Onclive Tv ,